LAUNXP BIOMEDICAL CO., LTD.(TW:6876)
NT$14.05+0.05 (+0.36%)
TW:6876
LAUNXP BIOMEDICAL CO., LTD. financials statements
NT$14.05
At close:+0.05 (+0.36%)
LAUNXP BIOMEDICAL CO., LTD. (6876) Income Statement
LAUNXP BIOMEDICAL CO., LTD. Income Statement
Last quarter (Q2 2026), LAUNXP BIOMEDICAL CO., LTD.'s total revenue was NT$720.00K. In Q2, LAUNXP BIOMEDICAL CO., LTD.'s net income was NT$-392.82M. See LAUNXP BIOMEDICAL CO., LTD.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 0.00 | NT$ 2.48M | NT$ 11.00K | NT$ 0.00 | NT$ 0.00 | |
| NT$ -2.52M | NT$ 2.29M | NT$ 11.00K | NT$ 0.00 | NT$ 0.00 | |
| NT$ 108.40M | NT$ 84.59M | NT$ 81.06M | NT$ 43.62M | NT$ 34.83M | |
| Depreciation and Amortization | NT$ 2.52M | NT$ 2.40M | NT$ 2.41M | NT$ 2.35M | NT$ 1.60M |
| NT$ -108.40M | NT$ -79.65M | NT$ -78.37M | NT$ -41.07M | NT$ -33.08M | |
| NT$ -110.93M | NT$ -82.30M | NT$ -81.05M | NT$ -43.42M | NT$ -34.69M | |
| NT$ 919.00K | NT$ 213.00K | NT$ 100.00K | NT$ -195.00K | NT$ -61.00K | |
| NT$ -110.01M | NT$ -82.09M | NT$ -80.95M | NT$ -43.61M | NT$ -34.75M | |
| NT$ -110.01M | NT$ -82.59M | NT$ -80.95M | NT$ -43.61M | NT$ -34.75M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.78 | NT$ -3.51 | NT$ -3.44 | NT$ -2.42 | NT$ -2.06 |
| Diluted EPS | NT$ -2.78 | NT$ -3.51 | NT$ -3.44 | NT$ -2.42 | NT$ -2.06 |
| Weighted Average Shares Outstanding | 39.56M | 23.53M | 23.53M | 18.02M | 16.87M |
| Weighted Average Shares Outstanding (Diluted) | 39.56M | 23.53M | 23.53M | 18.02M | 16.87M |
Currency in TWD

